Bluesky Facebook Reddit Email

Mayo Clinic researchers map prostate cancer relapse using C-11 choline PET and MRI

10.05.16 | Mayo Clinic

Apple iPhone 17 Pro

Apple iPhone 17 Pro delivers top performance and advanced cameras for field documentation, data collection, and secure research communications.

ROCHESTER, Minn. - A team of Mayo Clinic researchers has, for the first time, successfully mapped patterns of prostate cancer recurrence, following surgery. Using C-11 choline PET imaging and multiparametric MRI, researchers found an anatomically diverse pattern of recurrence, which may help optimize treatment of patients whose prostate cancer returns after surgery. The research findings are published today in the Journal of Urology .

"This study has important implications for men who have a rising prostate-specific antigen (PSA) test, also known as biochemical recurrence, after radical prostatectomy for prostate cancer," says Jeffrey Karnes, M.D., a urological surgeon at Mayo Clinic. "In men with biochemical recurrence, determining where the disease has recurred is quite challenging, especially when the PSA level is low."

According to Dr. Karnes, in the U.S., approximately 30 percent of patients who have had an initial prostate cancer surgically excised will suffer a recurrence and seek treatment. "Current imaging tests like conventional bone and CT scans are not sensitive enough to identify sites of recurrence, especially when the PSA value is lower than 10," he says.

Dr. Karnes says the combination of C-11 choline PET scanning and multiparametric MRI, helps physicians accurately identify sites of recurrence at an average PSA of 2. More importantly, he says, "This type of staging allows us to identify sites of recurrent disease that can be potentially treated either surgically or with radiation."

Dr. Karnes and his team also were able to describe patterns of prostate cancer recurrence. They found that nearly two-thirds of men in the study had recurrence limited to the pelvis, which potentially can be targeted for radiation therapy.

###

Co-authors are:

All authors are from Mayo Clinic

About Mayo Clinic

Mayo Clinic is a nonprofit organization committed to clinical practice, education and research, providing expert, whole-person care to everyone who needs healing. For more information, visit http://www.mayoclinic.org/about-mayo-clinic or http://newsnetwork.mayoclinic.org/ .

The Journal of Urology

Keywords

Article Information

Contact Information

Source

How to Cite This Article

APA:
Mayo Clinic. (2016, October 5). Mayo Clinic researchers map prostate cancer relapse using C-11 choline PET and MRI. Brightsurf News. https://www.brightsurf.com/news/LP2MQZNL/mayo-clinic-researchers-map-prostate-cancer-relapse-using-c-11-choline-pet-and-mri.html
MLA:
"Mayo Clinic researchers map prostate cancer relapse using C-11 choline PET and MRI." Brightsurf News, Oct. 5 2016, https://www.brightsurf.com/news/LP2MQZNL/mayo-clinic-researchers-map-prostate-cancer-relapse-using-c-11-choline-pet-and-mri.html.